Capecitabine monotherapy for recurrent and metastatic nasopharyngeal carcinoma

被引：0
|
作者：
Mehdi, A. [1 ]
Hela, R. [1 ]
机构：
[1] Salah Azaiz Inst, Tunis, Tunisia
来源：
ORAL ONCOLOGY | 2009年
关键词：
D O I：
10.1016/j.oos.2009.06.497
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：191 / 191
页数：1
相关论文
共 50 条
  • [31] Phase II study of gefitinib for the treatment of recurrent and metastatic nasopharyngeal carcinoma
    Chua, Daniel T. T.
    Wei, William I.
    Wong, Maria P.
    Sham, Jonathan S. T.
    Nicholls, John
    Au, Gordon K. H.
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2008, 30 (07): : 863 - 867
  • [32] Efficacy and safety of apatinib in recurrent/metastatic nasopharyngeal carcinoma: A pilot study
    Huang, Luo
    Zhang, Xin
    Bai, Yu
    Chua, Kevin L. M.
    Xie, Yue
    Shu, Xiaolei
    Long, Bin
    Fan, Chunbo
    Lim, Darren W. T.
    Tan, Sze Huey
    Wee, Joseph T. S.
    Wang, Ying
    Wu, Yongzhong
    Chua, Melvin L. K.
    ORAL ONCOLOGY, 2021, 115
  • [33] CHEMOTHERAPY OF METASTATIC AND OR RECURRENT UNDIFFERENTIATED NASOPHARYNGEAL CARCINOMA WITH CISPLATIN, BLEOMYCIN, AND FLUOROURACIL
    BOUSSEN, H
    CVITKOVIC, E
    WENDLING, JL
    AZLI, N
    BACHOUCHI, M
    MAHJOUBI, R
    KALIFA, C
    WIBAULT, P
    SCHWAAB, G
    ARMAND, JP
    JOURNAL OF CLINICAL ONCOLOGY, 1991, 9 (09) : 1675 - 1681
  • [34] Comprehensive treatment of recurrent and metastatic nasopharyngeal carcinoma: advances and future directions
    Fan, Ming
    Liu, Dengqun
    Zhu, Guiquan
    Ren, Yazhou
    Feng, Mei
    PRECISION RADIATION ONCOLOGY, 2022, 6 (04): : 328 - 334
  • [35] Multicenter phase II study of capecitabine combined with nedaplatin for recurrent and metastatic nasopharyngeal carcinoma patients after failure of cisplatin-based chemotherapy
    Peng, Pei-Jian
    Ou, Xue-Qing
    Chen, Zhi-Bin
    Liao, Hai
    Peng, Yu-Long
    Wang, Si-Yang
    Zhang, Hong-Yu
    Lin, Zhong
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2013, 72 (02) : 323 - 328
  • [36] Multicenter phase II study of capecitabine combined with nedaplatin for recurrent and metastatic nasopharyngeal carcinoma patients after failure of cisplatin-based chemotherapy
    Pei-Jian Peng
    Xue-Qing Ou
    Zhi-Bin Chen
    Hai Liao
    Yu-Long Peng
    Si-Yang Wang
    Hong-Yu Zhang
    Zhong Lin
    Cancer Chemotherapy and Pharmacology, 2013, 72 : 323 - 328
  • [37] Anlotinib for patients with recurrent or metastatic nasopharyngeal carcinoma: A phase II study.
    Cai, Qingqing
    Su, Ning
    Fang, Yu
    Zou, Qihua
    Xia, Yi
    Ma, Shuyun
    Cai, Jun
    Liu, PanPan
    Wang, Jinni
    Zhang, Yuchen
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16) : E18020 - E18020
  • [38] Detection and staging of recurrent or metastatic nasopharyngeal carcinoma in the era of FDG PET/MR
    Yongfeng Piao
    Caineng Cao
    Yuanfan Xu
    Shuang Huang
    Feng Jiang
    Ting Jin
    Qifeng Jin
    Yonghong Hua
    Qiaoying Hu
    Xiaozhong Chen
    European Archives of Oto-Rhino-Laryngology, 2022, 279 : 353 - 359
  • [39] A Phase II trial of docetaxel and cisplatin in patients with recurrent or metastatic nasopharyngeal carcinoma
    McCarthy, JS
    Tannock, IF
    Degendorfer, P
    Panzarella, T
    Furlan, M
    Siu, LL
    ORAL ONCOLOGY, 2002, 38 (07) : 686 - 690
  • [40] ACUTE BLINDNESS DURING TREATMENT OF RECURRENT OR METASTATIC NASOPHARYNGEAL CARCINOMA WITH DOXORUBICIN AND CCNU
    SCHORNAGEL, JH
    VERWEIJ, J
    DEMULDER, PHM
    WILDIERS, J
    KIRKPATRICK, A
    COGNETTI, F
    EUROPEAN JOURNAL OF CANCER, 1990, 26 (07) : 857 - 857
12345